These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 22846869)
21. Limited value of CA 19-9 in predicting early treatment failure in patients with advanced pancreatic cancer. Vormittag L; Gleiss A; Scheithauer W; Lang F; Laengle F; Kornek GV Oncology; 2009; 77(2):140-6. PubMed ID: 19628952 [TBL] [Abstract][Full Text] [Related]
22. Predictors of malignant intraductal papillary mucinous neoplasm of the pancreas. Mimura T; Masuda A; Matsumoto I; Shiomi H; Yoshida S; Sugimoto M; Sanuki T; Yoshida M; Fujita T; Kutsumi H; Ku Y; Azuma T J Clin Gastroenterol; 2010 Oct; 44(9):e224-9. PubMed ID: 20453661 [TBL] [Abstract][Full Text] [Related]
23. [Small pancreatic cancer diagnosis and prognosis]. Zhang JW; Sun YM; Bian ZM; Shi SS; Wang CF; Zhao P Zhonghua Zhong Liu Za Zhi; 2009 May; 31(5):375-9. PubMed ID: 19799088 [TBL] [Abstract][Full Text] [Related]
24. [Current diagnosis and treatment of early pancreatic cancer]. Ryu S; Maeshiro K; Yasunami Y; Ikeda S Nihon Rinsho; 1996 May; 54(5):1390-4. PubMed ID: 8965372 [TBL] [Abstract][Full Text] [Related]
25. Long-term survival following resection of brain metastases from pancreatic cancer. Lemke J; Barth TF; Juchems M; Kapapa T; Henne-Bruns D; Kornmann M Anticancer Res; 2011 Dec; 31(12):4599-603. PubMed ID: 22199336 [TBL] [Abstract][Full Text] [Related]
26. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer. Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733 [TBL] [Abstract][Full Text] [Related]
27. Undetectable preoperative levels of serum CA 19-9 correlate with improved survival for patients with resectable pancreatic adenocarcinoma. Berger AC; Meszoely IM; Ross EA; Watson JC; Hoffman JP Ann Surg Oncol; 2004 Jul; 11(7):644-9. PubMed ID: 15197014 [TBL] [Abstract][Full Text] [Related]
28. Management of sporadic pancreatic desmoid tumors. Hina M; Lynch BA; Herdman AV; Stanley JD Am Surg; 2012 Jan; 78(1):E1-3. PubMed ID: 22273281 [No Abstract] [Full Text] [Related]
29. Prognostic impact of postoperative serum CA 19-9 levels in patients with resectable pancreatic cancer. Hata S; Sakamoto Y; Yamamoto Y; Nara S; Esaki M; Shimada K; Kosuge T Ann Surg Oncol; 2012 Feb; 19(2):636-41. PubMed ID: 21863360 [TBL] [Abstract][Full Text] [Related]
30. Clinicopathological features in misdiagnosed pancreatic carcinoma. Nagahama H; Okada S; Okusaka T; Ishii H; Ikeda M; Nakasuka H; Yoshimori M Hepatogastroenterology; 1999; 46(29):2983-5. PubMed ID: 10576387 [TBL] [Abstract][Full Text] [Related]
31. The definition of locally advanced pancreatic cancer. Zanini N; Masetti M; Jovine E Br J Cancer; 2010 Apr; 102(8):1306-7; author reply 1308. PubMed ID: 20354530 [No Abstract] [Full Text] [Related]
33. Could standard ISO 15189 be useful for the conundrum of CA 19-9/GI Monitor measurement? Dorizzi RM; Meneghelli S; Rocca M; Ferrari A Clin Chem Lab Med; 2007; 45(7):928-9. PubMed ID: 17617041 [No Abstract] [Full Text] [Related]
37. Management of borderline and locally advanced pancreatic cancer: where do we stand? He J; Page AJ; Weiss M; Wolfgang CL; Herman JM; Pawlik TM World J Gastroenterol; 2014 Mar; 20(9):2255-66. PubMed ID: 24605025 [TBL] [Abstract][Full Text] [Related]
39. Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies. Mehta J; Prabhu R; Eshpuniyani P; Kantharia C; Supe A Trop Gastroenterol; 2010; 31(3):190-4. PubMed ID: 21560524 [TBL] [Abstract][Full Text] [Related]
40. Primary pancreatic lymphoma: a clinical quandary of diagnosis and treatment. Du X; Zhao Y; Zhang T; Liao Q; Dai M; Liu Z; Guo J; Hu Y Pancreas; 2011 Jan; 40(1):30-6. PubMed ID: 20683215 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]